Saegis, formerly David Pharmaceuticals, Inc., is dedicated to developing new medicines that protect and improve memory and cognition. Ivarson's name development methodology focuses on a brand's key attributes. The new corporate name combines the words “sage” for wisdom and “aegis” for shield to position the company as a market leader in clinical development of pharmaceuticals for the protection and enhancement of the function of the human mind.